41760-84-3Relevant articles and documents
Propofol phosphamide derivative, preparation method and medical application thereof
-
Paragraph 0089; 0093-0097, (2021/02/24)
The invention discloses a propofol phosphamide derivative, a preparation method and medical application thereof, and relates to a compound represented by a general formula (I), a stereoisomer or a pharmaceutically acceptable salt thereof, and applications in medicine, wherein the structure of the compound represented by the general formula (I) is represented by the following formula, and the groupdefinition is consistent with the definition in the specification.
Phosphonoformic acid esters and pharmaceutical compositions containing same
-
, (2008/06/13)
A pharmaceutical preparation containing as active ingredient a compound of the formula STR1 wherein R1 and R2 are the same or different, and each is selected from the group consisting of hydrogen, alkyl groups containing 1-6 carbon atoms; cycloalkyl groups containing 3-6 carbon atoms; cycloalkyl-alkyl groups containing 4-6 carbon atoms; 1-adamantyl; 2-adamantyl, benzyl; and phenyl groups of the formula STR2 wherein R4 and R5 are the same or different and each is selected from the group consisting of hydrogen, halogen, alkyl having 1, 2, or 3 carbon atoms, alkoxy having 1, 2, or 3 carbon atoms, alkoxycarbonyl having 2-7 carbon atoms and alkylcarbonyl groups having 2-7 carbon atoms; or R4 and R5 together form a straight saturated alkylene chain having 3 or 4 carbon atoms and being bound to adjacent positions, i.e. 2,3- or 3,4- in the phenyl ring; and R3 is selected from the group consisting of hydrogen, alkyl groups containing 1-8 carbon atoms; cycloalkyl groups containing 3-8 carbon atoms; cycloalkyl-alkyl groups containing 4-8 carbon atoms; 1-adamantyl; 2-adamantyl; benzyl; and phenyl groups of the formula STR3 wherein R4 and R5 have the meaning given above; provided that at least one of the groups R1, R2 and R3 is alkyl, cycloalkyl, or cycloalkyl-alkyl as defined above, or 1-adamantyl, 2-adamantyl, or benzyl; and provided that when R3 is H, then one of R1 and R2 is alkyl, cycloalkyl, or cycloalkyl-alkyl as defined above, or 1-adamantyl, 2-adamantyl, or benzyl and the other of R1 and R2 is H; or a physiologically acceptable salt or an optical isomer thereof; novel compounds within formula I, methods for their preparation and their medicinal use.
